Breaking News

Tweet TWEET

BT And Accelrys Help Scientists Gain Valuable Medical Insights From Big Data

 BT And Accelrys Help Scientists Gain Valuable Medical Insights From Big Data

Innovations in cloud solutions help utilize public health data to gain
meaningful insight from massive datasets - so far shown nearly impossible with
other technologies

PR Newswire

SAN DIEGO, May 30, 2013

SAN DIEGO, May 30, 2013 /PRNewswire/ --BT and Accelrys, Inc. today announced
that the two companies are working closely together to help garner valuable
medical insights from vast public health datasets, using BT for Life Sciences
cloud compute solutions combined with Accelrys Enterprise Platform and
Accelrys Pipeline Pilot.

(Logo: http://photos.prnewswire.com/prnh/20120416/MM88629LOGO)

The United Kingdom (UK) state-funded National Health Service (NHS) has been in
existence for more than 60 years. During that period, the UK population has
generated a wealth of health data and much of this information is
computerized. In addition, a vast amount of information on the operational
delivery of health care has been made available under the UK open data
policy. Similar datasets are available in other countries, most notably from
the Food and Drug Administration (FDA) in the United States.

BT has collated publically available health system and social care information
into a research repository intended for use by the life sciences and health
care industries as well as academia, initially hosted in the United States and
UK, but available for global access. Such data can provide valuable insight
into a number of healthcare topics, such as disease prevalence, impact of
ethnic mix and adverse drug reactions. However, the information is often
contained in very large datasets and may be unstructured in nature.

The combination of BT's Cloud Compute platform, the Accelrys Enterprise
Platform and Pipeline Pilot has proved capable of finding buried value in
massive amounts of data. BT and Accelrys are focused on supporting the Big
Data challenges of their customers. This initiative demonstrates the
capabilities of their combined technology approaches as they focus through
their collaboration on developing solutions to address the significant market
need to unlock the value of large datasets. The mutual goal is to let the
scientist focus on science and not worry about the complexities of information
management, particularly in a cloud environment.

Accelrys, a Foundational Member of the BT for Life Sciences ecosystem, helps
provide research solutions to scientists on a global basis and recently made
its HEOS collaboration suite available on BT Cloud Compute platform. Accelrys
solutions are being further integrated into the BT for Life Science R&D
Workbench, which itself is built on the BT Cloud Compute IAAS platform. BT for
Life Sciences was one of the first cloud services designed to enable
collaboration within the life sciences industry for increased research and
development productivity.

"The generation of ever-increasing amounts of health data is both a blessing
and a curse, as they are data-rich, but often information-poor," said Leif
Pedersen, senior vice president of marketing, product management and corporate
development, Accelrys. "Working with BT, we've shown that we can deliver
meaningful and valuable insights from these huge datasets."

Bas Burger, President of Global Pharmaceutical & Chemical for BT Global
Services, said, "Building on the launch of BT for Life Sciences last year, we
are excited that our continued collaboration with Accelrys is bringing new
innovations to the life sciences industry. By making it easier for scientists
to gain valuable medical insights from anonymous data buried in large
datasets, we can help provide the interpretation of health outcomes. Working
together, BT and Accelrys are making such patient outcomes analysis available
to those companies developing drugs, enabling real-world outcomes that can be
linked to the drug development pipeline."

About BT

BT is one of the world's leading providers of communications services and
solutions, serving customers in more than 170 countries. Its principal
activities include the provision of networked IT services globally; local,
national and international telecommunications services to its customers for
use at home, at work and on the move; broadband and internet products and
services and converged fixed/mobile products and services. BT consists
principally of four lines of business: BT Global Services, BT Retail, BT
Wholesale and Openreach.

In the year ended 31 March 2013, BT Group's revenue was £18,017m with profit
before taxation of £2,501m.

British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group
plc and encompasses virtually all businesses and assets of the BT Group. BT
Group plc is listed on stock exchanges in London and New York.

For more information, visit www.btplc.com

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software, supports industries and organizations that rely
on scientific innovation to differentiate themselves. The industry-leading
Accelrys Enterprise Platform provides a broad and flexible scientific solution
optimized to integrate the diversity of science, experimental processes and
information requirements across the research, development, process scale-up
and early manufacturing phases of product development. By incorporating
capabilities in applications for modeling and simulation, enterprise lab
management, workflow and automation, and data management and informatics,
Accelrys enables scientific innovators to access, organize, analyze and share
data in unprecedented ways, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and speeding time from lab to
market.

Accelrys solutions are used by more than 1,300 companies in the
pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged
goods and industrial products industries. Headquartered in San Diego,
California, USA, Accelrys employs more than 200 full-time PhD scientists. For
more information about Accelrys, visit www.accelrys.com.

Related Links
Accelrys Website
Follow Accelrys on Twitter
Friend Accelrys on Facebook
Accelrys' YouTube Channel
Connect with Accelrys on LinkedIn

SOURCE Accelrys, Inc.

Website: http://www.accelrys.com
Contact: Press Inquiries, Susan Thomas, Racepoint Group for Accelrys,
415-694-6728, sthomas@racepointgroup.com, Kris Kozamchak, Head of PR and
Corporate Relations U.S., BT, 972-310-9055, kris.kozamchak@bt.com